Indian drugmaker Anthem Biosciences' ANTH.NS $395 million IPO was fully subscribed on the second day of bidding on Tuesday, ...

The Rs 3,395 crore Initial Public Offering (IPO) of Anthem Biosciences, the Bangalore-based contract research, development, ...

According to market observers, shares of the company are available at a premium of ₹101 in the grey market today ...

Anthem Biosciences IPO got fully subscribed at 1.15 times on the second day of share sale on July 15. The initial share sale ...

Anthem Biosciences IPO sees 20% GMP premium and strong subscriptions on Day 2; check allotment, listing, and key dates now!

The IPO opened for subscription on July 14, aims to raise Rs 3,395 crore through a complete offer for sale (OFS) of 5.96 ...

Anthem Biosciences' initial share sale received bids for 14,47,66,596 shares, as against 4,40,70,682 shares on offer, ...

Anthem Biosciences has launched its IPO on July 14, closing on July 16. The ₹3,395 crore offer is entirely for sale by ...

Anthem Biosciences IPO on Day 2 with moderate success, price band ₹540-570, 35% reserved for retail investors.

The mainline issue will close for public subscription on Wednesday, July 16. The basis of allotment of shares is likely to be ...

With a unique business model rooted in innovation-led drug development services, the company is betting big on global ...

Anthem Biosciences' IPO fully subscribed, investors optimistic about growth prospects amid global pharma shift from China to ...